36mon MSN
Tylenol's maker pushes back against possible label change linking use in pregnancy to autism
The American company that makes Tylenol says the FDA should not make proposed changes to the product’s safety label to reflect a possible connection to autism.
In today’s Pharmaceutical Executive Daily, we cover major leadership changes at Novo Nordisk, Kenvue’s request for the FDA to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback